Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Anobri Pharmaceuticals US, LLC et al

NPE Status

Practicing Entity

Declaratory Judgment

No

See case in Lex Machina

Civil Action

1:23-cv-00716

Filing Date

Jun 30, 2023

Venue

D.Del.

Termination Date

Sep 25, 2023

US Patent No

Patent Asserters:

Patent Asserter

Boehringer Ingelheim International GMBH

8 Product company

Boehringer Ingelheim Pharmaceuticals, Inc.

8 Product company

Alleged Infringers:

Anobri Pharmaceuticals US, LLC

NanChang Anovent Pharmaceutical Co., Ltd.

Shanghai Anovent Pharmaceutical Co., Ltd.